Day: September 22, 2018

  1. Home
  2. Archives: September 2018

Orphazyme closes a €14 million Series B Extension

Orphazyme closes a €14 million Series B Extension

Recent Posts

  • Apic Bio Announces $40M Series A Financing to Advance Novel Gene Therapies for Rare Genetic Disorders
  • Search for cure against the lethal disease ALS boosted by new investor
  • Orphazyme closes a €14 million Series B Extension
  • Amylyx Pharmaceuticals Receives FDA Orphan Drug Designation for AMX0035 for the Treatment of Amyotrophic Lateral Sclerosis
  • Project ALS and Amylyx Enter Collaboration to Test AMX0035

ROBERT BROWN

Scientific Advisory Board